Gerri Henwood
2020 - Baudax Bio
In 2020, Gerri Henwood earned a total compensation of $603.3K as President and Chief Executive Officer at Baudax Bio, a 79% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $111,240 |
|---|---|
| Salary | $308,654 |
| Stock Awards | $162,286 |
| Other | $21,166 |
| Total | $603,346 |
Henwood received $308.7K in salary, accounting for 51% of the total pay in 2020.
Henwood also received $111.2K in non-equity incentive plan, $162.3K in stock awards and $21.2K in other compensation.
Rankings
In 2020, Gerri Henwood's compensation ranked 10,488th out of 13,090 executives tracked by ExecPay. In other words, Henwood earned more than 19.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,488 out of 13,090 | 20th |
Division Services | 1,937 out of 2,341 | 17th |
Major group Health Services | 209 out of 252 | 17th |
Industry group Miscellaneous Health And Allied Services, Not | 35 out of 43 | 19th |
Source: SEC filing on March 11, 2021.
Henwood's colleagues
We found one more compensation record of an executive who worked with Gerri Henwood at Baudax Bio in 2020.
2020
Ryan Lake
Baudax Bio
Chief Financial Officer
News
Baudax Bio CEO Gerri Henwood's 2021 pay jumps 178% to $1.7M
March 31, 2022
Recro Pharma CFO Ryan Lake's 2020 pay jumps 161% to $2.2M
March 25, 2021
Baudax Bio CEO Gerri Henwood's 2020 pay falls 87% to $603K
March 11, 2021
Recro Pharma CEO Gerri Henwood's 2019 pay jumps 90% to $4.6M
March 27, 2020
Recro Pharma CEO Gerri Henwood's 2018 pay rises 16% to $2.4M
March 20, 2019